Heart Failure / CHF

We have participated in more than 1,200 clinical research trials (130 active trials) and have introduced most of the new techniques in cardiovascular medicine over the past 20 years.

Clinical Trials: Heart Failure / CHF

Description

Barostim Neo® - Baroreflex Activation Therapy® for Heart Failure

Investigator(s): O'brien

Enrolling

External Measure of Thoracic Fluid and Vital Signs

Investigator(s): Chung

Enrolling

A Double-blind, Randomized, Sham-procedure-controlled, Parallel-group Efficacy and Safety Study of Allogeneic Mesenchymal Precursor Cells (rexlemestrocel-L) in Patients With Chronic Heart Failure Due to Left Ventricular Systolic Dysfunction of Either Ischemic or Nonischemic Etiology

Investigator(s): Chung

Enrolling

A Double-blind, Randomized, Placebo-controlled, Multicenter Study to Assess the Efficacy and Safety of Omecamtiv Mecarbil on Mortality and Morbidity in Subjects With Chronic Heart Failure With Reduced Ejection Fraction (GALACTIC-HF)

Investigator(s): Chung

Enrolling

Diagnostics Driven Diuretic and Chronic Medication Management for Heart Failure

Investigator(s): Menon

Enrolling

A MULTINATIONAL TRIAL TO EVALUATE THE PARACHUTE IMPLANT SYSTEM: PARACHUTE PercutAneous Ventricular RestorAtion in Chronic Heart FailUre Due to Ischemic HearT DiseasE

Investigator(s): Chung

Enrolling

Prevention of Non-Surgical Bleeding by Management of HeartMate II Patients Without Antiplatelet Therapy

Investigator(s): Egnaczyk

Enrolling

Reveal LINQ™ Heart Failure

Investigator(s): Eugene Chung

Enrolling

A Prospective Phase I/II Dose Escalation Pilot Analysis of Ruboxistaurin (LY333531) for Safety in New York Heart Failure Classification III-IV Patients, As Well As For Efficacy in Acutely Augmenting Cardiac Function.

Investigator(s): Egnaczyk

Pending

Randomized, Double-Blind, Placebo-Controlled Phase I/II Study of the Safety and Efficacy of Intracoronary Delivery of Allogeneic Cardiosphere-Derived Cells in Patients With an Anterior Myocardial Infarction and Ischemic Left Ventricular Dysfunction

Investigator(s): Kereiakes

Follow up only